The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): Baxter International Inc. (BAX) pays a $0.04 annual dividend, yielding 0.15% at $25.83/share. Next ex-dividend date 2026-08-28. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.15%
Annual Dividend: $0.04 per share
Payout Ratio: -17.8%
Ex-Dividend Date: 2026-08-28
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 45
Baxter International Inc. dividend income is minimal at present: the current yield stands at just 0.15%. BAX operates across roughly 100 countries, supplying dialysis treatments, IV therapies, infusion pumps, and critical care products to hospitals, dialysis centers, and home patients. The trailing annual dividend rate is $0.04 per share, paid quarterly, with the next ex-dividend date on August 28, 2026. With a beta of 0.595, BAX stock moves well below the broader market, which appeals to investors who prioritize low volatility over high income.
Baxter International Inc. pays out -17.8% of earnings as dividends, a payout ratio classified as conservative (below 40%). A negative payout ratio reflects negative earnings in the trailing period, meaning the dividend is not currently covered by profits. Baxter International Inc. dividend safety hinges on whether the company returns to positive earnings, given that the current $0.04 annual rate is not supported by reported income. The most significant pressure point in the data is that negative earnings, not an elevated payout, is what puts the dividend at risk.
Baxter International Inc. dividend history shows a CAGR of 0.8% per year from 2008 to 2024. The per-share annual dividend moved from $0.9125 in 2008 to $1.04 in 2024 (2025 and 2026 figures are partial years and excluded from the growth calculation). The largest annual increase in the window was 24.1% in 2012, but the data also contains at least one year-over-year decline exceeding 5%, and the streak of consecutive annual increases currently stands at zero.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -23.2% | $1.15 (2022) | $0.52 (2025) |
| 5-Year | -11.4% | $0.95 (2020) | $0.52 (2025) |
| 10-Year | -8.5% | $1.27 (2015) | $0.52 (2025) |
BAX stock fits dividend investors who prioritize low market volatility over income, given its beta of 0.595 and a yield classified as low (below 2%). At 0.15%, the current yield is far below the 5-year average of 3.84%, a gap that reflects how sharply the dividend has been scaled back. The company's global footprint in dialysis, critical care, and IV therapies provides broad operational reach, but that breadth has not translated into dividend growth: the 16-year CAGR is just 0.8% and the consecutive-increase streak is zero. An investor in BAX accepts minimal income and no growth momentum in exchange for below-market price volatility.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-28 | $0.0100 |
| 2026-05-29 | $0.0100 |
| 2026-02-27 | $0.0100 |
| 2025-11-28 | $0.0100 |
| 2025-08-29 | $0.1700 |
| 2025-05-30 | $0.1700 |
| 2025-02-28 | $0.1700 |
| 2024-11-29 | $0.1700 |
| 2024-08-30 | $0.2900 |
| 2024-05-31 | $0.2900 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.0300 |
| 2025 | $0.5200 |
| 2024 | $1.0400 |
| 2023 | $1.1600 |
| 2022 | $1.1500 |
Project income from BAX with the BAX dividend calculator or track your full portfolio with the dividend tracker.